Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company founded in 1988 and headquartered in Bridgewater, New Jersey, focuses on rare diseases with investigational and approved therapies in pulmonary, inflammatory, and other…
HQ: Bridgewater, NJ, United States of Americawww.insmed.com
USD121.16+2.62%vs prev. close
Performance
1W
+8.56%
1M
+21.99%
3M
-6.54%
1Y
-39.26%
YTD
-32.16%
Valuation
P/E
—
EPS TTM
-2.88
Dividend yield
—
Size and risk
Market cap
$26.6B
Beta
0.81
Price history
INSM price
USD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
Insmed
INSM
Biotechnology
Mkt cap (USD bn)
26.6
P/E
—
Div yld
—
1W
+8.6%
1M
+22.0%
3M
-6.5%
6M
+2.1%
1Y
-39.3%
YTD
-32.2%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Insmed
INSM
Biotechnology
26.6
—
—
+8.6%
+22.0%
-6.5%
+2.1%
-39.3%
-32.2%
Subscribe to Equity Analytics to compare INSM with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.